114 related articles for article (PubMed ID: 1701060)
1. Cytoreductive hepatic surgery for neuroendocrine tumors.
McEntee GP; Nagorney DM; Kvols LK; Moertel CG; Grant CS
Surgery; 1990 Dec; 108(6):1091-6. PubMed ID: 1701060
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.
Jensen EH; Kvols L; McLoughlin JM; Lewis JM; Alvarado MD; Yeatman T; Malafa M; Shibata D
Ann Surg Oncol; 2007 Feb; 14(2):780-5. PubMed ID: 17146740
[TBL] [Abstract][Full Text] [Related]
4. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
5. Surgical experience with functioning pancreatic neuroendocrine tumors.
Matthews BD; Smith TI; Kercher KW; Holder WD; Heniford BT
Am Surg; 2002 Aug; 68(8):660-5; discussion 665-6. PubMed ID: 12206598
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
9. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
[TBL] [Abstract][Full Text] [Related]
10. Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control?
Al-Sanea N; Isbister WH
ANZ J Surg; 2004 Apr; 74(4):229-32. PubMed ID: 15043733
[TBL] [Abstract][Full Text] [Related]
11. [Surgery for non-colorectal and non-neuroendocrine liver metastases].
Zacherl M; Längle F; Steininger R; Scheuba C; Wenzl E; Jakesz R; Zacherl J
Wien Klin Wochenschr; 2001 Sep; 113(17-18):681-7. PubMed ID: 11603103
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery in patients with advanced-stage carcinoid tumors.
Gulec SA; Mountcastle TS; Frey D; Cundiff JD; Mathews E; Anthony L; O'Leary JP; Boudreaux JP
Am Surg; 2002 Aug; 68(8):667-71; discussion 671-2. PubMed ID: 12206599
[TBL] [Abstract][Full Text] [Related]
13. Survival after repeat hepatic resection for recurrent colorectal metastases.
Chiappa A; Zbar AP; Biella F; Staudacher C
Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668
[TBL] [Abstract][Full Text] [Related]
14. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
Gillams A; Cassoni A; Conway G; Lees W
Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207
[TBL] [Abstract][Full Text] [Related]
16. Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan.
Hibi T; Sano T; Sakamoto Y; Takahashi Y; Uemura N; Ojima H; Shimada K; Kosuge T
Jpn J Clin Oncol; 2007 Feb; 37(2):102-7. PubMed ID: 17234654
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and surgical treatment of metastatic lung tumors].
Yamamoto Y; Hirata T; Fukuse T; Yokomise H; Ike O; Mizuno H; Wada H; Hitomi S; Nakamura T; Shimizu Y
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1248-54. PubMed ID: 8831735
[TBL] [Abstract][Full Text] [Related]
18. Aggressive surgery for liver metastases from gastrointestinal stromal tumors.
Shima Y; Horimi T; Ishikawa T; Ichikawa J; Okabayashi T; Nishioka Y; Hamada M; Shibuya Y; Ishii T; Ito M
J Hepatobiliary Pancreat Surg; 2003; 10(1):77-80. PubMed ID: 12827476
[TBL] [Abstract][Full Text] [Related]
19. Cryosurgical ablation of hepatic metastases from colorectal carcinomas.
Yeh KA; Fortunato L; Hoffman JP; Eisenberg BL
Am Surg; 1997 Jan; 63(1):63-8. PubMed ID: 8985074
[TBL] [Abstract][Full Text] [Related]
20. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
